US Stock MarketDetailed Quotes

BLACU Bellevue Life Sciences Acquisition Corp.

Watchlist
  • 11.890
  • 0.0000.00%
Close Nov 29 09:30 ET
0Market Cap0.00P/E (TTM)

About Bellevue Life Sciences Acquisition Corp. Company

Bellevue Life Sciences Acquisition Corp. is a blank check company. Its objectives are to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.

Company Profile

SymbolBLACU
Company NameBellevue Life Sciences Acquisition Corp.
Listing DateFeb 10, 2023
Issue Price10.00
Founded2020
CEOMr. Kuk Hyoun Hwang
MarketNASDAQ
Employees2
Fiscal Year Ends12-31
Address10900 NE 4th Street,Suite 2300
CityBellevue
ProvinceWashington
CountryUnited States of America
Zip Code98004
Phone1-425-635-7700

Company Executives

  • Name
  • Position
  • Salary
  • Kuk Hyoun Hwang
  • Chief Executive Officer and Director
  • --
  • David Jin Yoo
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Jun Chul Whang
  • Director
  • --
  • Sang Hyun Kim
  • Independent Director
  • --
  • Jin Whan Park
  • Independent Director
  • --
  • Phil Geon Lee
  • Independent Director
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.